Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 May 2021 | Story Ilze Bakkes

The COVID-19 outbreak in South Africa and the subsequent national lockdown severely impacted the usual physical open day mass-marketing tactic. At the same time, it provided an opportunity for the Department of Student Recruitment Services (SRS) to be super creative and agile in promoting the UFS offerings to the target audiences. 

Once a year, the UFS invites prospective learners and parents to visit our campuses for a taste of campus life. But for many interested students, especially those living remotely or abroad, a site visit is not always practical. Furthermore, the 2021 open days on the Bloemfontein and Qwaqwa Campuses were again cancelled due to the COVID-19 pandemic. The 2020 Virtual Open Day proved that breaking from the traditional recruitment tactics and moving into the virtual domain was not only bold and innovative, but also offered more engagement and communication opportunities with prospective students. Building on the insights and success of COVID-19 response engagements, the Department of Student Recruitment Services has once again developed an immersive virtual experience for prospective students. 

Ilze Bakkes, Chief Officer: Integrated Marketing and Innovation from the Department of Student Recruitment Services, says: “We listened to the needs and wants of our prospective students and staff. Therefore, the 2021 Virtual Expo will have undergraduate, postgraduate, and international student recruitment foci, offering more and relevant information in a visual, multi-layered, and digital way.” Information is presented through videos, photos, downloadable PDF brochures, and links to marketing material and the online application platform. 

A challenge during the physical open day is the lack of time to engage with faculties or that not all the information could be obtained. The Virtual Expo is live now click here and can be visited until 30 September 2021, when applications to study undergraduate and postgraduate programmes in 2022 close. The Virtual Expo offers a professional, easy-to-navigate and hassle-free digital experience of the academic, social, and cultural life at the UFS on all three campuses – in the convenience of the visitor’s own space and time. Subtexts for videos enable differently abled visitors to enjoy the content, and data-sensitive visitors can download the PDF versions of videos. 

Applications to study in 2022 are already open. To apply, click here (link to online application). For important closing dates, download the UFS Undergraduate Prospectus

For information on the Virtual Expo, contact Ilze Bakkes at +27 51 401 9028 or bakkese@ufs.ac.za.

News Archive

Carbon dioxide makes for more aromatic decaffeinated coffee
2017-10-27


 Description: Carbon dioxide makes for more aromatic decaffeinated coffee 1b Tags: Carbon dioxide makes for more aromatic decaffeinated coffee 1b 

The Inorganic Group in the Department of Chemistry
at the UFS is systematically researching the utilisation
of carbon dioxide. From the left, are, Dr Ebrahiem Botha,
Postdoctoral Fellow; Mahlomolo Khasemene, MSc student;
Prof André Roodt; Dr Marietjie Schutte-Smith, Senior Lecturer;
and Mokete Motente, MSc student.
Photo: Charl Devenish

Several industries in South Africa are currently producing hundreds of thousands of tons of carbon dioxide a year, which are released directly into the air. A typical family sedan doing around 10 000 km per year, is annually releasing more than one ton of carbon dioxide into the atmosphere.

The Inorganic Chemistry Research Group in the Department of Chemistry at the University of the Free State (UFS), in collaboration with the University of Zurich in Switzerland, has focused in recent years on using carbon dioxide – which is regarded as a harmful and global warming gas – in a meaningful way. 

According to Prof André Roodt, Head of Inorganic Chemistry at the UFS, the Department of Chemistry has for the past five decades been researching natural products that could be extracted from plants. These products are manufactured by plants through photosynthesis, in other words the utilisation of sunlight and carbon dioxide, nitrogen, and other nutrients from the soil.

Caffeine and chlorophyll 
“The Inorganic group is systematically researching the utilisation of carbon dioxide. Carbon dioxide is absorbed by plants through chlorophyll and used to make interesting and valuable compounds and sugars, which in turn could be used for the production of important new medicines,” says Prof Roodt.

Caffeine, a major energy enhancer, is also manufactured through photosynthesis in plants. It is commonly found in tea and coffee, but also (artificially added) in energy drinks. Because caffeine is a stimulant of the central nervous system and reduces fatigue and drowsiness, some people prefer decaffeinated coffee when enjoying this hot drink late at night. 

Removing caffeine from coffee could be expensive and time-consuming, but also environmentally unfriendly, because it involves the use of harmful and flammable liquids. Some of the Inorganic Group’s research focus areas include the use of carbon dioxide for the extraction of compounds, such as caffeine from plants. 

“Therefore, the research could lead to the availability of more decaffeinated coffee products. Although decaffeinated coffee is currently aromatic, we want to investigate further to ensure better quality flavours,” says Prof Roodt.

Another research aspect the team is focusing on is the use of carbon dioxide to extract chlorophyll from plants which have medicinal properties themselves. Chemical suppliers sell chlorophyll at R3 000 a gram. “In the process of investigating chlorophyll, our group discovered simpler techniques to comfortably extract larger quantities from green vegetables and other plants,” says Prof Roodt.

Medicines
In addition, the Inorganic Research Group is also looking to use carbon dioxide as a building block for more valuable compounds. Some of these compounds will be used in the Inorganic Group’s research focus on radiopharmaceutical products for the identification and possibly even the treatment of diseases such as certain cancers, tuberculosis, and malaria.

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept